This brand name is authorized in Australia, Brazil, Canada, Estonia, Spain, Finland, France, Ireland, Japan, Lithuania, Mexico, Netherlands, New Zealand, Romania, Tunisia, Turkey, United Kingdom, United States
The drug HYDREA contains one active pharmaceutical ingredient (API):
|
1
Hydroxycarbamide
UNII X6Q56QN5QC - HYDROXYUREA
|
|
One of the mechanisms by which hydroxycarbamide acts is the elevation of foetal haemoglobin (HbF) concentrations in sickle cell patients. In addition hydroxycarbamide causes an immediate inhibition of DNA synthesis by acting as a ribonucleotide reductase inhibitor, without interfering with the synthesis of ribonucleic acid or protein. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| HYDREA Capsule | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L01XX05 | Hydroxycarbamide | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 3093T |
| Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 505102501117316 |
| Country: CA | Health Products and Food Branch | Identifier(s): 00465283 |
| Country: EE | Ravimiamet | Identifier(s): 1036022, 1615698, 1878251 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 61633 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 521757 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 69700567 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 23907 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 61832 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 4229001M1027 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1002639, 1066848, 1082392 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 508M2015 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 2690 |
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 643 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W03542001 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 5253081 |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699525156679 |
| Country: US | FDA, National Drug Code | Identifier(s): 0003-0830 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
